Work

Endothelial α ν β 3 Integrin–Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis

Year: 2006

Type: article

Source: Arteriosclerosis Thrombosis and Vascular Biology

DOI: 10.1161/01.atv.0000235724.11299.76

Authors: Patrick M. Winter, Anne M. Neubauer, Shelton D. Caruthers, Thomas D. Harris, J. David Robertson, Todd A. Williams, Anne H. Schmieder, Grace Hu, John S. Allen, Elizabeth K. Lacy, Huiying Zhang, Samuel A. Wickline, Gregory M. Lanza

Institutions: Washington University in St. Louis, Bristol-Myers Squibb (United States), University of Missouri

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering

Awards: G2082730119, Anti-Inflammatory Therapeutics for Cardiovascular Disease, Molecular Imaging of Angiogenesis by MRI, Combined Therapeutic-Imaging Agent for Atherosclerosis

OpenAlex ID: W2112285684

FWCI: 11.22

Cites: 31

Cited by: 382

Related to: 10